Insider Trading & Ownership - Karas Eric

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Karas Eric
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-18
Sale
2024-09-19
4:30 pm
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$14$140,000600,281
(Direct)
View
2024-08-19
Sale
2024-08-21
6:51 pm
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$14$140,000610,281
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-18
Exercise
2024-09-19
4:30 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$1.5600,281
(Direct)
View
2024-09-18
Exercise
2024-09-19
4:30 pm
N/A
2032-05-23
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$0600,281
(Direct)
View
2024-08-19
Exercise
2024-08-21
6:51 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$1.5610,281
(Direct)
View
2024-08-19
Exercise
2024-08-21
6:51 pm
N/A
2032-05-23
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
10,000$0610,281
(Direct)
View
2024-01-02
Option Award
2024-01-04
4:47 pm
N/A
2034-01-01
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
200,000$0200,000
(Direct)
View
2023-01-03
Option Award
2023-01-05
5:00 pm
N/A
2033-01-02
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
50,000$050,000
(Direct)
View
2022-11-08
Option Award
2022-11-10
6:00 pm
N/A
2032-05-24
ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer
614,588$0614,588
(Direct)
View